LEADER 01866nam  2200433Ia 450 
001 9910698807403321
005 20090604163702.0
035   $a(CKB)5470000002397796
035   $a(OCoLC)370471736
035   $a(EXLCZ)995470000002397796
100   $a20090604d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $euse of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2009]
215   $ai, 14 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 4, 2009).
300   $a"Draft guidance".
300   $a"March 2009".
300   $aIncludes bibliographical references (p. 12-14).
517   $aGuidance for industry 
606   $aTrypanosoma cruzi$zUnited States$xPrevention
606   $aBlood$xTransfusion$xGovernment policy$zUnited States
606   $aCell transplantation$xGovernment policy$zUnited States
606   $aTransplantation of organs, tissues, etc$xGovernment policy$zUnited States
615  0$aTrypanosoma cruzi$xPrevention.
615  0$aBlood$xTransfusion$xGovernment policy
615  0$aCell transplantation$xGovernment policy
615  0$aTransplantation of organs, tissues, etc.$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698807403321
996   $aGuidance for industry$93434577
997   $aUNINA

LEADER 01756nam  2200565   450 
001 9910827659003321
005 20211105140617.0
010   $a1-58983-971-4
024 7 $a2027/heb32652
035   $a(CKB)3710000000202411
035   $a(SSID)ssj0001291654
035   $a(PQKBManifestationID)11761005
035   $a(PQKBTitleCode)TC0001291654
035   $a(PQKBWorkID)11249206
035   $a(PQKB)10398011
035   $a(MiAaPQ)EBC3118322
035   $a(Au-PeEL)EBL3118322
035   $a(CaPaEBR)ebr10897561
035   $a(CaONFJC)MIL767768
035   $a(OCoLC)890067736
035   $a(dli)HEB32652
035   $a(MiU)  MIU01100000000000000000254
035   $a(EXLCZ)993710000000202411
100   $a20140730h20142014  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aSourcebook for ancient Mesopotamian medicine /$fby JoAnn Scurlock
210  1$aAtlanta, Georgia :$cSociety of Biblical Literature,$d2014.
210  4$dİ2014
215   $a1 online resource (785 pages)
225 1 $aWritings from the Ancient World ;$vNumber 36
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-58983-970-6 
311   $a1-58983-969-2 
320   $aIncludes bibliographical references and index.
410  0$aWritings from the ancient world ;$vNumber 36.
606   $aMedicine, Assyro-Babylonian$vSources
615  0$aMedicine, Assyro-Babylonian
676   $a610.935
700   $aScurlock$b Jo Ann$f1953-$0845934
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910827659003321
996   $aSourcebook for ancient Mesopotamian medicine$91888857
997   $aUNINA